Annonce • Jan 09
Kaspien Holdings Files Form 15 Kaspien Holdings Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common Stock was $0.01 per share. Annonce • Dec 19
Kaspien Holdings' Delisting of Common Stock from OTCQB Expected to Become Effective on or About January 8, 2024 On December 18, 2023, Kaspien Holdings Inc., pursuant to an authorization by its board of directors (the “Board”), issued a press release regarding its intent to file a Form 25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about December 28, 2023. As a result, the Company expects the delisting of its common stock from the OTCQB to become effective on or about January 8, 2024. The Company also will be taking steps to deregister as a public company under the Securities Exchange Act of 1934 (the “Securities Act”). Annonce • Dec 13
Kaspien Holdings Inc. announced delayed 10-Q filing On 12/12/2023, Kaspien Holdings Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Annonce • May 27
Kaspien Holdings Inc., Annual General Meeting, Jun 28, 2023 Kaspien Holdings Inc., Annual General Meeting, Jun 28, 2023, at 10:00 Pacific Standard Time. Agenda: To elect four directors to serve one-year terms and until their successors are chosen and qualified; to ratify the appointment of fruci & associates ii, pllc as our independent registered public accounting firm for the fiscal year ending February 3, 2024; and; to transact such other business as may properly come before the meeting or any adjournment or adjournments thereof. Annonce • May 24
Kaspien Holdings Announces Voluntary Delisting from The Nasdaq Stock Market LLC and Intent to File Form 25 with the U.S. Securities and Exchange Commission On May 22, 2023, Kaspien Holdings Inc. notified The Nasdaq Stock Market LLC (‘Nasdaq’) of the company's decision to voluntarily delist its common stock from The Nasdaq Capital Market and its intent to file a Form 25 with the U.S. Securities and Exchange Commission (the ‘SEC’) on or about June 1, 2023. As a result, the Company expects the delisting of its common stock to become effective on or about June 12, 2023. As previously noted on the Company's Current Report on Form 8-K filed with the SEC on December 15, 2022 and on the Company's Current Report on Form 8-K filed with the SEC on May 8, 2023, the Company had received written notices from Nasdaq that the Company was not in compliance with the minimum bid price and minimum stockholders' equity requirements, respectively, for continued listing on The Nasdaq Capital Market. After careful evaluation of the options available to the Company, the Company's board of directors (the ‘Board’) has determined that the voluntary delisting of the Company's common stock from The Nasdaq Capital Market is in the best interests of the Company and its stockholders. The Board's decision was based on careful review of several factors, including the likely inability of the Company to regain compliance with the foregoing Nasdaq listing rules and the significant costs associated therewith. In addition, the Board believes a delisting provides the Company and its stockholders lower operating costs and management time commitment for compliance activities. The Company anticipates that its common stock will be quoted on the OTCQB or other market operated by OTC Markets Group Inc. (the ‘OTC’), and it intends to take such actions to enable its common stock to be quoted on the OTCQB or on another OTC market so that a trading market may continue to exist for its common stock. There is no guarantee, however, that a broker will continue to make a market in the common stock and that trading of the common stock will continue on an OTC market or otherwise. At this time, the Company is not taking steps to deregister as a public company under the Securities Exchange Act of 1934. Annonce • May 10
Kaspien Holdings Inc. Receives Non-Compliance Written Notice from Nasdaq As previously noted on the Company's Form 8-K filed with the Securities and Exchange Commission on December 15, 2022, Kaspien Holdings Inc. (the Company") had received written notice from The Nasdaq Stock Market (Nasdaq") that the Company is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), and must regain compliance with that requirement by June 12, 2023. Separately, on May 4, 2023, the Company received written notice from Nasdaq that given the reported stockholders' equity on the Company's Form 10-K for the year ended January 28, 2023, the Company also is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). In accordance with the Nasdaq Listing Rules, the Company has been provided a period of 45 calendar days, or until June 20, 2023, to submit a plan to Nasdaq to regain compliance with the minimum stockholders' equity requirement. If the Company's plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of its letter, or until October 31, 2023, for the Company to evidence compliance. If the Company's plan is not accepted, the Company expects that at that time Nasdaq will provide written notice to the Company that the Company's common stock will be subject to delisting. Neither notice has an immediate impact on the listing of the Company's common stock, which will continue to trade on The Nasdaq Capital Market. The Company continues to monitor its closing bid price for its common stock and to consider available options to resolve the Company's noncompliance with the minimum bid price requirement and noncompliance with the minimum stockholders' equity requirement. Reported Earnings • Apr 30
Full year 2023 earnings released: US$5.47 loss per share (vs US$3.28 loss in FY 2022) Full year 2023 results: US$5.47 loss per share (further deteriorated from US$3.28 loss in FY 2022). Revenue: US$128.2m (down 11% from FY 2022). Net loss: US$19.0m (loss widened 137% from FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings. Major Estimate Revision • Dec 20
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from US$134.6m to US$128.4m. Losses expected to increase from US$4.05 per share to US$4.57. Software industry in the US expected to see average net income growth of 13% next year. Consensus price target down from US$6.00 to US$3.00. Share price fell 7.4% to US$0.68 over the past week. Reported Earnings • Dec 15
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: US$0.92 loss per share (further deteriorated from US$0.36 loss in 3Q 2022). Revenue: US$29.1m (down 9.4% from 3Q 2022). Net loss: US$3.56m (loss widened 302% from 3Q 2022). Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 24%. Revenue is forecast to stay flat during the next 2 years compared to a 13% growth forecast for the Software industry in the US. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Price Target Changed • Nov 16
Price target decreased to US$6.00 Down from US$60.00, the current price target is provided by 1 analyst. New target price is 582% above last closing price of US$0.88. Stock is down 94% over the past year. The company is forecast to post a net loss per share of US$4.05 next year compared to a net loss per share of US$3.28 last year. Reported Earnings • Sep 14
Second quarter 2023 earnings released: US$1.69 loss per share (vs US$0.033 profit in 2Q 2022) Second quarter 2023 results: US$1.69 loss per share (down from US$0.033 profit in 2Q 2022). Revenue: US$33.9m (down 2.8% from 2Q 2022). Net loss: US$4.42m (down US$4.50m from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 15
First quarter 2023 earnings released: US$1.78 loss per share (vs US$0.61 loss in 1Q 2022) First quarter 2023 results: US$1.78 loss per share (down from US$0.61 loss in 1Q 2022). Revenue: US$31.8m (down 22% from 1Q 2022). Net loss: US$4.43m (loss widened 213% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 114% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Reported Earnings • May 01
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: US$3.28 loss per share (down from US$2.11 loss in FY 2021). Revenue: US$143.7m (down 9.2% from FY 2021). Net loss: US$8.03m (loss widened 106% from FY 2021). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 138%. Over the next year, revenue is forecast to grow 6.6%, compared to a 35% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Price Target Changed • Apr 27
Price target decreased to US$40.00 Down from US$60.00, the current price target is provided by 1 analyst. New target price is 618% above last closing price of US$5.57. Stock is down 76% over the past year. The company is forecast to post a net loss per share of US$1.38 next year compared to a net loss per share of US$2.10 last year. Breakeven Date Change • Dec 15
No longer forecast to breakeven The analyst covering Kaspien Holdings no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of US$794.0k in 2023. New forecast suggests the company will make a loss of US$1.11m in 2023. Reported Earnings • Dec 13
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: US$0.36 loss per share (down from US$1.40 profit in 3Q 2021). Revenue: US$32.2m (down 17% from 3Q 2021). Net loss: US$886.0k (down 135% from profit in 3Q 2021). Revenue missed analyst estimates by 12%. Earnings per share (EPS) also missed analyst estimates by 14%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 11%, compared to a 203% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$13.63, the stock trades at a trailing P/E ratio of 31.5x. Average forward P/E is 55x in the Software industry in the US. Total loss to shareholders of 27% over the past three years. Valuation Update With 7 Day Price Move • Sep 21
Investor sentiment deteriorated over the past week After last week's 21% share price decline to US$16.01, the stock trades at a trailing P/E ratio of 37x. Average forward P/E is 58x in the Software industry in the US. Total loss to shareholders of 16% over the past three years. Reported Earnings • Sep 15
Second quarter 2022 earnings released: EPS US$0.033 (vs US$0.49 loss in 2Q 2021) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: US$34.9m (down 18% from 2Q 2021). Net income: US$82.0k (up US$981.0k from 2Q 2021). Profit margin: 0.2% (up from net loss in 2Q 2021). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.